Is Less More: Does Leukopenia Predict Remission in Patients with Inflammatory Bowel Disease Receiving Thiopurine Treatment?

被引：2
|
作者：
Gisbert, Javier P. [1 ,2 ]
机构：
[1] Hosp Univ La Princesa, Gastroenterol Unit, Inst Invest Sanitaria Princesa, Madrid 28669, Spain
[2] Hosp Univ La Princesa, Ctr Invest Biomed Red Enfermedades Hepaticas & Di, Madrid 28669, Spain
来源：
DIGESTIVE DISEASES AND SCIENCES | 2015年 / 60卷 / 01期
关键词：
AZATHIOPRINE THERAPY; 6-MERCAPTOPURINE; NEUTROPENIA;
D O I：
10.1007/s10620-014-3481-z
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：4 / 6
页数：3
相关论文
共 50 条
  • [41] Genotype-Guided Thiopurine Dosing Does not Lead to Additional Costs in Patients With Inflammatory Bowel Disease
    Sluiter, Reinier L.
    van Marrewijk, Corine
    de Jong, Dirk
    Scheffer, Hans
    Guchelaar, Henk-Jan
    Derijks, Luc
    Wong, Dennis R.
    Hooymans, Piet
    Vermeulen, Sita H.
    Verbeek, Andre L. M.
    Franke, Barbara
    van der Wilt, Gert Jan
    Kievit, Wietske
    Coenen, Marieke J. H.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 (07): : 838 - 845
  • [42] PACSIN2 Does Not Influence Thiopurine-Related Toxicity In Patients With Inflammatory Bowel Disease
    Roberts, Rebecca L.
    Wallace, Mary C.
    Seinen, Margien L.
    Krishnaprasad, Krupa
    Chew, Angela
    Lawrance, Ian
    Prosser, Ruth
    Bampton, Peter
    Grafton, Rachel
    Simms, Lisa
    Radford-Smith, Graham
    Andrews, Jane M.
    Barclay, Murray L.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 (06): : 925 - 927
  • [43] Combined detection variants of NUDT15 could highly predict thiopurine-induced leukopenia in Chinese patients with inflammatory bowel disease: a multi-center analysis
    Chao, K.
    Zhu, X.
    Cao, Q.
    Yang, H.
    Liang, J.
    Lin, L.
    Huang, Z.
    Zhang, Y.
    Huang, Y.
    Sun, Y.
    Xue, X.
    Huang, M.
    Hu, P.
    Wu, K.
    Lan, P.
    Wang, X.
    Qian, J.
    Gao, X.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S125 - S125
  • [44] Pharmacogenetics during standardised initiation of thiopurine treatment in inflammatory bowel disease
    Hindorf, U.
    Lindqvist, M.
    Peterson, C.
    Soderkvist, P.
    Strom, M.
    Hjortswang, H.
    Pousette, A.
    Almer, S.
    GUT, 2006, 55 (10) : 1423 - 1431
  • [45] Safety of azathioprine and 6-mercaptopurine in patients with inflammatory bowel disease naive to thiopurine treatment
    Alaish, Ram
    Lundgren, David
    Suhr, Ole B.
    Werner, Marten
    Karling, Pontus
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2017, 55 (07) : 594 - 600
  • [46] Can we predict myelotoxicity development during thiopurine therapy for inflammatory bowel disease?
    Kharitonov, A.
    Shchukina, O.
    Lapin, S.
    Bulgakova, T.
    Baranovsky, A.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S293 - S293
  • [47] Hypoxanthine guanine phosphoribosyltransferase activity is related to 6-thioguanine nucleotide concentrations and thiopurine-induced leukopenia in the treatment of inflammatory bowel disease
    Ding, Liang
    Zhang, Fang-bin
    Liu, Hui
    Gao, Xiang
    Bi, Hui-chang
    Wang, Xue-ding
    Chen, Bai-li
    Zhang, Yu
    Zhao, Li-zi
    Zhong, Guo-ping
    Hu, Pin-jin
    Chen, Min-hu
    Huang, Ming
    INFLAMMATORY BOWEL DISEASES, 2012, 18 (01) : 63 - 73
  • [48] Monitoring Thiopurine Metabolites in Korean Pediatric Patients with Inflammatory Bowel Disease
    Kim, Mi Jin
    Lee, Soo Youn
    Choe, Yon Ho
    YONSEI MEDICAL JOURNAL, 2014, 55 (05) : 1289 - 1296
  • [49] The Impact of Thiopurine Hypermethylation on Clinical Outcomes in Patients With Inflammatory Bowel Disease
    Blaker, Paul A.
    Fong, Steven C.
    Smith, Melissa A.
    Kariyawasam, Viraj C.
    Marinaki, Anthony M.
    Irving, Peter M.
    Sanderson, Jeremy D.
    GASTROENTEROLOGY, 2014, 146 (05) : S246 - S246
  • [50] THIOPURINE MONITORING IN INFLAMMATORY BOWEL DISEASE PATIENTS AT A DISTRICT GENERAL HOSPITAL
    Jowitt, T.
    Bowman, C.
    Ahmed, M.
    Singh, S.
    Lim, C. H.
    GUT, 2012, 61 : A403 - A403
12345